Enveric Biosciences, Inc. (ENVB) vs Traws Pharma, Inc. (TRAW)
- Enveric Biosciences, Inc. ENVB 1.38 −0.72%
- Traws Pharma, Inc. TRAW 0.37 −7.50%
Enveric Biosciences, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Traws Pharma, Inc. are of similar size ($6.2M and $6.2M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against −13.9%. Across the 12 metrics below, Enveric Biosciences, Inc. leads on 6 and Traws Pharma, Inc. on 6.
Valuation
Profitability
| Metric | ENVB | TRAW | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (235.48%) | (319.42%) | (56.36%) |
| Return on assets | (193.53%) | (117.35%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack